However, as reported for gastric cancer, TAMs are capable of silencing TSG gelsolin in cancer cells by increased DNMT1 expression and DNA methylation of gelsolin promoter via activation of CCL5/CCR5/STAT3 signaling [228]. Here, CCR5 is linked to gastric cancer.